Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 16, 2023

BUY
$1.79 - $4.17 $27,029 - $62,967
15,100 New
15,100 $50,000
Q2 2022

Aug 15, 2022

BUY
$1.76 - $3.22 $6,864 - $12,558
3,900 Added 17.65%
26,000 $57,000
Q1 2022

May 16, 2022

SELL
$2.88 - $4.23 $24,192 - $35,532
-8,400 Reduced 27.54%
22,100 $70,000
Q3 2021

Nov 15, 2021

BUY
$7.0 - $9.71 $36,400 - $50,492
5,200 Added 20.55%
30,500 $248,000
Q2 2021

Aug 11, 2021

SELL
$7.55 - $9.42 $201,585 - $251,514
-26,700 Reduced 51.35%
25,300 $191,000
Q1 2021

May 17, 2021

BUY
$8.23 - $11.48 $153,901 - $214,676
18,700 Added 56.16%
52,000 $451,000
Q4 2020

Feb 16, 2021

BUY
$7.65 - $8.98 $81,090 - $95,188
10,600 Added 46.7%
33,300 $265,000
Q3 2020

Nov 16, 2020

SELL
$7.37 - $11.54 $616,132 - $964,743
-83,600 Reduced 78.65%
22,700 $181,000
Q2 2020

Aug 14, 2020

BUY
$6.28 - $10.59 $441,484 - $744,477
70,300 Added 195.28%
106,300 $1.05 Million
Q1 2020

May 15, 2020

BUY
$3.77 - $7.73 $135,720 - $278,280
36,000 New
36,000 $278,000
Q4 2018

Feb 14, 2019

SELL
$7.05 - $12.64 $192,465 - $345,072
-27,300 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$10.95 - $14.8 $194,910 - $263,440
-17,800 Reduced 39.47%
27,300 $352,000
Q2 2018

Aug 14, 2018

SELL
$6.9 - $12.35 $244,950 - $438,425
-35,500 Reduced 44.04%
45,100 $514,000
Q1 2018

May 15, 2018

BUY
$6.55 - $8.2 $232,525 - $291,100
35,500 Added 78.71%
80,600 $568,000
Q4 2017

Feb 14, 2018

BUY
$5.9 - $7.05 $266,090 - $317,955
45,100
45,100 $293,000

Others Institutions Holding CTSO

About Cytosorbents Corp


  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $40.1M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.